Hi:
I was wondering what people are doing with their miRNA data to quantitate
miR and miR* from their sequence reads (SOLID in my case).Especially novel miR*.
(I wish they change miR* nomenclature to more sensible 3p-5p one)
Is anybody aware of any computational approaches to automate miR vs miR*
quantitation? Also I was wondering how people are addressing sense - antisense
mapping issues related to ds regions in pre-miRs?
Thanks
-
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...Today, 06:46 AM -
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM